2-169191972-C-T

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_ModerateBP6BP7BS1BS2

The NM_004525.3(LRP2):​c.8892G>A​(p.Arg2964=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00664 in 1,614,188 control chromosomes in the GnomAD database, including 50 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0053 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0068 ( 47 hom. )

Consequence

LRP2
NM_004525.3 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: 0.230
Variant links:
Genes affected
LRP2 (HGNC:6694): (LDL receptor related protein 2) The protein encoded by this gene, low density lipoprotein-related protein 2 (LRP2) or megalin, is a multi-ligand endocytic receptor that is expressed in many different tissues but primarily in absorptive epithilial tissues such as the kidney. This glycoprotein has a large amino-terminal extracellular domain, a single transmembrane domain, and a short carboxy-terminal cytoplasmic tail. The extracellular ligand-binding-domains bind diverse macromolecules including albumin, apolipoproteins B and E, and lipoprotein lipase. The LRP2 protein is critical for the reuptake of numerous ligands, including lipoproteins, sterols, vitamin-binding proteins, and hormones. This protein also has a role in cell-signaling; extracellular ligands include parathyroid horomones and the morphogen sonic hedgehog while cytosolic ligands include MAP kinase scaffold proteins and JNK interacting proteins. Recycling of this membrane receptor is regulated by phosphorylation of its cytoplasmic domain. Mutations in this gene cause Donnai-Barrow syndrome (DBS) and facio-oculoacoustico-renal syndrome (FOAR).[provided by RefSeq, Aug 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 2-169191972-C-T is Benign according to our data. Variant chr2-169191972-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 211403.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Benign=1, Uncertain_significance=1}.
BP7
Synonymous conserved (PhyloP=0.23 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00528 (804/152334) while in subpopulation NFE AF= 0.00875 (595/68026). AF 95% confidence interval is 0.00817. There are 3 homozygotes in gnomad4. There are 357 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
LRP2NM_004525.3 linkuse as main transcriptc.8892G>A p.Arg2964= synonymous_variant 48/79 ENST00000649046.1 NP_004516.2
LRP2XM_011511183.4 linkuse as main transcriptc.8892G>A p.Arg2964= synonymous_variant 48/78 XP_011509485.1
LRP2XM_047444340.1 linkuse as main transcriptc.7968G>A p.Arg2656= synonymous_variant 48/79 XP_047300296.1
LRP2XM_011511184.3 linkuse as main transcriptc.6603G>A p.Arg2201= synonymous_variant 33/64 XP_011509486.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
LRP2ENST00000649046.1 linkuse as main transcriptc.8892G>A p.Arg2964= synonymous_variant 48/79 NM_004525.3 ENSP00000496870 P1

Frequencies

GnomAD3 genomes
AF:
0.00528
AC:
804
AN:
152216
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00113
Gnomad AMI
AF:
0.0515
Gnomad AMR
AF:
0.00432
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00320
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00875
Gnomad OTH
AF:
0.00382
GnomAD3 exomes
AF:
0.00493
AC:
1238
AN:
251222
Hom.:
5
AF XY:
0.00495
AC XY:
672
AN XY:
135770
show subpopulations
Gnomad AFR exome
AF:
0.00123
Gnomad AMR exome
AF:
0.00367
Gnomad ASJ exome
AF:
0.00199
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00105
Gnomad FIN exome
AF:
0.00286
Gnomad NFE exome
AF:
0.00830
Gnomad OTH exome
AF:
0.00555
GnomAD4 exome
AF:
0.00678
AC:
9911
AN:
1461854
Hom.:
47
Cov.:
31
AF XY:
0.00679
AC XY:
4938
AN XY:
727234
show subpopulations
Gnomad4 AFR exome
AF:
0.000986
Gnomad4 AMR exome
AF:
0.00376
Gnomad4 ASJ exome
AF:
0.00138
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00131
Gnomad4 FIN exome
AF:
0.00391
Gnomad4 NFE exome
AF:
0.00812
Gnomad4 OTH exome
AF:
0.00513
GnomAD4 genome
AF:
0.00528
AC:
804
AN:
152334
Hom.:
3
Cov.:
32
AF XY:
0.00479
AC XY:
357
AN XY:
74494
show subpopulations
Gnomad4 AFR
AF:
0.00113
Gnomad4 AMR
AF:
0.00431
Gnomad4 ASJ
AF:
0.00144
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000415
Gnomad4 FIN
AF:
0.00320
Gnomad4 NFE
AF:
0.00875
Gnomad4 OTH
AF:
0.00378
Alfa
AF:
0.00509
Hom.:
0
Bravo
AF:
0.00527
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00774
EpiControl
AF:
0.00777

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Donnai-Barrow syndrome Benign:2
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 15, 2021- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
not provided Benign:2
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024LRP2: BP4, BP7, BS2 -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoSep 26, 2014- -
LRP2-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesMay 22, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
1.9
DANN
Benign
0.53

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs149148763; hg19: chr2-170048482; COSMIC: COSV104378890; API